All posts in Biologics
MiMedx Is Issued Three New U.S. Patents For Placental Tissue Allografts
MARIETTA, Ga., June 11, 2013 /PRNewswire/ – MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its receipt of three newly issued patents related to tissue allografts derived …
Israeli inventions underpin 20% of global biotech revenue
Israel's life sciences industry is manic-depressive. One moment, it's preparing for catastrophe and pending collapse, and the next, it's celebrating the industry's hoped-for breakthrough. There is no argument
SANUWAVE Appoints Daniel M. Jorgensen as Chief Medical Officer
ALPHARETTA, Ga., May 1, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced the Company has appointed Daniel M. Jorgensen, MD, MPH, MBA as its Chief Medical
ISTO assumes full control of Zimmer cartilage implant
ISTO Technologies Inc. announced an agreement with Zimmer Holdings Inc. giving ISTO full control of the DeNovo ET Engineered Tissue program, an engineered cartilage implant intended to repair
Wright Medical Group Inc. completes acquisition of BioMimetic Therapeutics
Wright Medical Group Inc. recently announced that it has completed its acquisition of BioMimetic Therapeutics Inc. According to a company release, the move will further accelerate growth opportunities in
Groundbreaking Discovery Of Cell Nucleus Structure Crucial To Understanding Diseases
Genes relocated from their correct position in the nucleus cause them to malfunction and this may lead to the heart, blood vessels and muscles breaking down. This new
Artimplant AB : New Head of Research and Development at Artimplant
Human Bone Grown From Stem Cells
Bilione W. Young • Mon, Jun 18th, 2012
Scientists at the Israeli biotechnology company Bonus BioGroup Ltd. have grown human bone from stem cells. Using stem cells taken fromOsiris Receives Medicare Reimbursement Codes for Grafix(R)
COLUMBIA, Md., May 29, 2012 (BUSINESS WIRE) -- Osiris Therapeutics, Inc. OSIR +3.34% , the leading stem cell company focused on developing and commercializing products to treat medical conditions
Medtronic receives notification that U.S. Department Of Justice and U.S. Attorney’s office have closed their investigation of activities relating to Infuse® bone graft
MINNEAPOLIS – MAY 16, 2012 – Medtronic, Inc. (NYSE: MDT) today announced it has been notified by the U.S. Department of Justice (DOJ) and the Office of the United States Attorney for the
Surgical sealant technology from HyperBranch gets CE Mark
Wound and surgical sealant developerHyperBranch Medical Technology has received the CE Mark for an applicator that delivers its sealant used in cranial and spinal surgeries. The Adherus AutoSpray Dural Sealant
Smith & Nephew Biologics new Joint Venture with Essex Woodlands – An Interview with Mark Augusti
We recently heard the news about Smith & Nephew selling 51% of their Biologics division to Essex Woodlands in a Joint Venture. We caught up with the new
BioRestorative (BRTX): Two Huge Markets, One Solid Business Model
BioRestorative Therapies Inc. (OTCQB: BRTX), an emerging leader in autologous adult stem cell treatments for the disc/spine, metabolic disorders, and obesity, operating alongside companies like Pluristem Therapeutics Inc.
Regentis Biomaterials Announces $10 Million Raised in Latest Round of Funding
OR AKIVA, Israel and PRINCETON, New Jersey, May 14, 2012 -- /PRNewswire/ -- Regentis Biomaterials Ltd., a privately held company focused on developing proprietary hydrogels for tissue regeneration, announced
